Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
This study has been completed.
Study NCT00314860 Information provided by GlaxoSmithKline
First Received: April 13, 2006 Last Updated: May 21, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Restless Legs Syndrome (RLS)
Additional conditions recognized in this trial
Psychomotor Agitation
Restless Legs Syndrome
Syndrome
More general conditions related to this trial
Disease
Dyskinesias
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Parasomnias
Pathologic Processes
Psychomotor Disorders
Signs and Symptoms
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
ropinirole Extended Release (XR)
Additional drug interventions recognized in this trial
Ropinirole
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline
Back to top of Main Content
